To uncover the drug-response landscape of cancers expressing upregulated PSMA7, we analyzed the potential connection of drug sensitivity with this gene mRNA expression across pan-cancers based on the drug sensitivity in cancer (GDSC) and cancer therapeutics response portal (CTRP) databases. This evidence concerns the gene PSMA7 and cancer.